Pharmacological interventions for the treatment of smokeless tobacco use

CNS Drugs

Volumn 26, Issue 1, 2012, Pages 1-10

  Ebbert, Jon O ^a   Fagerstrom, Karl ^b  

^a MAYO CLINIC   (United States)

^b Fagerstrom Consulting AB   (Sweden)

Author keywords

Bupropion; Drug dependence; Nicotine; Nicotine replacement therapy; Varenicline

Indexed keywords

AMFEBUTAMONE; DRUGS USED IN THE TREATMENT OF ADDICTION; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; NOSE SPRAY; UNCLASSIFIED DRUG; VARENICLINE;

ARTICLE; BEHAVIOR THERAPY; CANCER RISK; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; INHALER; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LOZENGE; MEDLINE; META ANALYSIS (TOPIC); MOUTH CANCER; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCANDINAVIA; SELF REPORT; SMOKELESS TOBACCO; SMOKING CESSATION; STROKE; SUSTAINED DRUG RELEASE; SYSTEMATIC REVIEW (TOPIC); TOBACCO DEPENDENCE; TREATMENT DURATION; UNITED STATES; WEIGHT CHANGE; WEIGHT GAIN; WITHDRAWAL SYNDROME;

BUPROPION; HUMANS; NICOTINIC AGONISTS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TOBACCO, SMOKELESS; TREATMENT OUTCOME;

EID: 83455186148     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11598450-000000000-00000     Document Type: Article

References (50)

1. Critchley JA, Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003; 58 (5): 435-43 (Pubitemid 36560948)
2. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: summary of national findings. Rockville (MD): Substance Abuse and Mental Health Services Administration, 2011
3. Swedish National Institute of Public Health. Tobacco habits [online]. Available from URL: http://www.fhi.se/en/High lights/National-Survey-of-Public- Health/Living-habits/Tobacco-habits-/[Accessed 2011 Sep 6]
4. Lund KE, Tefre EM, Amundsen A, et al. Cigarette smoking, use of snuff and other risk behaviour among students [in Norwegian]. Tidsskr Nor Laegeforen 2008 Aug 28; 128 (16): 1808-11
5. Substance Abuse andMental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: volume I. Summary of national findings [online]. Available from URL: http://oas.samhsa.gov/NSDUH/2k9 NSDUH/2k9Results.htm#Ch4 [Accessed 2011 Sep 6]
6. Royal College of Physicians. Harm reduction in nicotine addiction: helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians [online]. Available from URL: http://book shop.rcplondon.ac.uk/details.aspx?e=234 [Accessed 2011 Sep 6]
7. Boffetta P, Hecht S, Gray N, et al. Smokeless tobacco and cancer. Lancet Oncol 2008 Jul; 9 (7): 667-75 (Pubitemid 351878052)
8. Stockwell HG, Lyman GH. Impact of smoking and smokeless tobacco on the risk of cancer of the head and neck. Head Neck Surg 1986; 9 (2): 104-10
9. Goodman MT, Morgenstern H, Wynder EL. A case-control study of factors affecting the development of renal cell cancer. Am J Epidemiol 1986 Dec; 124 (6): 926-41 (Pubitemid 17207261)
10. Muscat JE, Hoffmann D, Wynder EL. The epidemiology of renal cell carcinoma: a second look. Cancer 1995; 75 (10): 2552-7
11. Muscat JE, Stellman SD, Hoffmann D, et al. Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomarkers Prev 1997 Jan; 6 (1): 15-9 (Pubitemid 27030422)
12. Stepanov I, Jensen J, Hatsukami D, et al. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res 2008 Dec; 10 (12): 1773-82
13. Foulds J, Ramstrom L, Burke M, et al. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003 Dec; 12 (4): 349-59 (Pubitemid 39452035)
14. Rutqvist LE, Curvall M, Hassler T, et al. Swedish snus and the GothiaTekstandard. Harm Reduct J 2011; 8: 11
15. Henley SJ, Thun MJ, Connell C, et al. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005 May; 16 (4): 347-58 (Pubitemid 40897827)
16. Swedish National Institute of Public Health. Tobacco, supervision and availability: an interview study and a systematic literature review regarding availability restriction methods [online]. Available from URL: http://www. fhi.se/en [Accessed 2011 Sep 6]
17. Severson HH. Enough snuff: ST cessation from the behavioral, clinical, and public health perspectives: monograph Smokeless tobacco or health: an international perspective [online]. Available from URL: http://cancercontrol. cancer.gov/tcrb/monographs/2/index.html [Accessed 2011 Sep 6]
18. Ebbert J, Montori VM, Erwin PJ, et al. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev 2011; (2): CD004306
19. Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline 2008 [online]. Available from URL: www.surgeongeneral. gov/tobacco/treating-tobacco-use08.pdf [Accessed 2011 Oct 12]
20. Ebbert JO, Croghan IT, Severson HH, et al. A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in midwestern United States. Nicotine Tob Res 2011 Sep; 13 (9): 820-6
21. Fagerstrom K, Gilljam H, Metcalfe M, et al. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. BMJ 2010; 341: c6549
22. Dale LC, Ebbert JO, Schroeder DR, et al. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study. Nicotine Tob Res 2002 Aug; 4 (3): 267-74 (Pubitemid 34994140)
23. Dale LC, Ebbert JO, Glover ED, et al. Bupropion SR for the treatment of smokeless tobacco use. Drug Alcohol Depend 2007 Sep 6; 90 (1): 56-63 (Pubitemid 46935371)
24. Boyle RG. Smokeless tobacco cessation with nicotine replacement: a randomized clinical trial. Diss Abstr Int 1992; 54 (3-A): 825
25. Ebbert JO, Dale LC, Patten CA, et al. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users. Nicotine Tob Res 2007 Jan; 9 (1): 43-52 (Pubitemid 47009043)
26. Ebbert JO, Severson HH, Croghan IT, et al. A randomized clinical trial of nicotine lozenge for smokeless tobacco use. Nicotine Tob Res 2009 Dec; 11 (12): 1415-23
27. Ebbert JO, Severson HH, Croghan IT, et al. A pilot study of mailed nicotine lozenges with assisted self-help for the treatment of smokeless tobacco users. Addict Behav 2010 May; 35 (5): 522-5
28. Hatsukami DK, Jensen J, Allen S, et al. Effects of behavioral and pharmacological treatment on smokeless tobacco users. J Consult Clin Psychol 1996 Feb; 64 (1): 153-61 (Pubitemid 26076077)
29. Hatsukami DK, Grillo M, Boyle R, et al. Treatment of spit tobacco users with transdermal nicotine system and mint snuff. J Consult Clin Psychol 2000; 68 (2): 241-9
30. Howard-Pitney B, Killen JD, Fortmann SP. Quitting chew: results from a randomized trial using nicotine patches. Exp Clin Psychopharmacol 1999 Nov; 7 (4): 362-71
31. Stotts RC, Roberson PK, Hanna EY, et al. A randomised clinical trial of nicotine patches for treatment of spit tobacco addiction among adolescents. Tob Control 2003 Dec; 12 Suppl. 4: IV11-5 (Pubitemid 39452027)
32. Rennard SI, Glover ED, Leischow S, et al. Efficacy of the nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine Tob Res 2006 Aug; 8 (4): 555-64 (Pubitemid 44263589)
33. Batra A, Klingler K, Landfeldt B, et al. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther 2005 Dec; 78 (6): 689-96 (Pubitemid 41773644)
34. Wennike P, Danielsson T, Landfeldt B, et al. Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction 2003 Oct; 98 (10): 1395-402 (Pubitemid 37297246)
35. Carpenter MJ, Hughes JR, Solomon LJ, et al. Both smoking reduction with nicotine replacement therapy andmotivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol 2004 Jun; 72 (3): 371-81 (Pubitemid 38679635)
36. Moore D, Aveyard P, Connock M, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009; 338: b1024
37. Wang D, Connock M, Barton P, et al. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess 2008 Feb; 12 (2): iii-iv, ix-xi, 1-135
38. Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res 2006 Dec; 8 (6): 739-49 (Pubitemid 44842952)
39. Ebbert JO, Croghan IT, North F, et al. A pilot study to assess smokeless tobacco use reduction with varenicline. Nicotine Tob Res 2010 Oct; 12 (10): 1037-40
40. Ebbert JO, Edmonds A, Luo X, et al. Smokeless tobacco reduction with the nicotine lozenge and behavioral intervention. Nicotine Tob Res 2010 Aug; 12 (8): 823-7
41. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res. Epub 2011 Oct 24
42. Andersson G, Bjornberg G, CurvallM. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. J Oral Pathol Med 1994; 23 (4): 161-7 (Pubitemid 2082988)
43. Ebbert JO, Post JA, Moyer TP, et al. Nicotine percentage replacement among smokeless tobacco users with nicotine patch. Drug Alcohol Depend 2007 Jul 10; 89 (2-3): 223-6 (Pubitemid 46754675)
44. Fagerstrom K, Furberg H. A comparison of the Fagerstrom Test for Nicotine Dependence and smoking prevalence across countries. Addiction 2008 May; 103 (5): 841-5 (Pubitemid 351537692)
45. Ebbert JO, Dale LC, Vickers KS, et al. Residential treatment for smokeless tobacco use: a case series. J Subst Abuse Treat 2004 Jun; 26 (4): 261-7 (Pubitemid 38759142)
46. Ebbert JO, Klinkhammer MD, Stevens SR, et al. A survey of characteristics of smokeless tobacco users in a treatment program. Am J Health Behav 2005 Jan-Feb; 29 (1): 25-35 (Pubitemid 40139034)
47. Hughes JR, Solomon LJ, Livingston AE, et al. A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit. Drug Alcohol Depend 2010 Sep 1; 111 (1-2): 105-13
48. Pfizer. A study to evaluate the efficacy and safety of varenicline compared to placebo for smoking cessation through reduction [ClinicalTrials.gov identifier NCT01370356]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://clinicaltrials.gov [Accessed 2011 Aug 28]
49. Ebbert JO, Hays JT, Hurt RD. Combination pharmacotherapy for stopping smoking: what advantages does it offer? Drugs 2010 Apr 16; 70 (6): 643-50
50. Ebbert JO, Croghan IT, Sood A, et al. Varenicline and bupropion sustained-release combination therapy for smoking cessation. Nicotine Tob Res 2009 Mar; 11 (3): 234-9